Replies to post #1184 on Can Fite BioPharma Ltd (CANF)

[Spideyboy]

I know, the M/C is laughable. currently worth just less than the 6 million they just raised!

But with no news until a partnership on Liver Cancer Phase III and NASH Phase II data output slated for 2H2019, which probably means in about 5 months, then they will continue to burn through cash at about 2-3 million per quarter. RA and Psoriasis Phase IIIs are just noted in the last company presentation as 'ongoing', no timeline set.

I only see this going down, though mildly, until one of those happens.

Even if there is a partnership I would expect the partner to take advantage of the situation and offer a deal with low upfront, so more cash will be needed.

I'm starting to feel bad for these guys, it's not even their fault. The liver cancer data was just skewed by mathematically impossible odds.